Jade Biosciences (JBIO) Current Leases (2021 - 2025)
Jade Biosciences (JBIO) reported Current Leases of $312000.0 for Q1 2025, down 29.89% on a YoY basis from $445000.0 in Q1 2024, and down 25.18% quarter-over-quarter from $417000.0 in Q4 2024.
Jade Biosciences (JBIO) Current Leases (2021 - 2025) Analysis & Trends
Jade Biosciences has reported Current Leases for 5 years, with the latest figure at $312000.0 in Q1 2025.
- For the quarter ending Q1 2025, Current Leases fell 29.89% year-over-year to $312000.0; the trailing twelve-month figure through Mar 2025 stood at $312000.0 (down 29.89% YoY), and the FY2024 full-year result was $417000.0, down 0.71% from the prior year.
- Current Leases for Q1 2025 stood at $312000.0, down from $417000.0 in the prior quarter.
- The five-year high for Current Leases was $475000.0 in Q2 2024, with the low at $147000.0 in Q3 2021.
- Historically, Current Leases has averaged $358266.7 across 5 years, with a median of $379000.0 in 2022.
- Annual changes were most pronounced in 2022 — Current Leases jumped 157.82% — and 2025, when it declined 29.89%.
- Jade Biosciences' Current Leases stood at $192000.0 in 2021, then surged by 100.52% to $385000.0 in 2022, then increased by 9.09% to $420000.0 in 2023, then slipped by 0.71% to $417000.0 in 2024, then dropped by 25.18% to $312000.0 in 2025.
- The last three Current Leases figures came in at $312000.0 (Q1 2025), $417000.0 (Q4 2024), and $459000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Jade Biosciences | 973.55 Mn | 973.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 312,000.00 |
| Dec 31, 2024 | 417,000.00 |
| Sep 30, 2024 | 459,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Mar 31, 2024 | 445,000.00 |
| Dec 31, 2023 | 420,000.00 |
| Sep 30, 2023 | 451,000.00 |
| Jun 30, 2023 | 379,000.00 |
| Mar 31, 2023 | 373,000.00 |
| Dec 31, 2022 | 385,000.00 |
| Sep 30, 2022 | 379,000.00 |
| Jun 30, 2022 | 347,000.00 |
| Mar 31, 2022 | 193,000.00 |
| Dec 31, 2021 | 192,000.00 |
| Sep 30, 2021 | 147,000.00 |